ArticleOncoimmunology

Co-delivery of the NKT agonist α-galactosylceramide and tumor antigens to cross-priming dendritic cells breaks tolerance to self-antigens and promotes antitumor responses.

Reem Ghinnagow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.